GGrantIndex
Sort

64,565 grants matching drug discovery

Selective C(sp3)-H Oxidations and Functionalizations with Tunable Metal Catalysts for Synthesis

$549,475
Maria Christina White · University Of Illinois At Urbana-Champaign · R35 · FY2022 · GM

Selective C(sp3)-H Oxidations and Functionalizations with Tunable Metal Catalysts for Synthesis

$549,475
Maria Christina White · University Of Illinois At Urbana-Champaign · R35 · FY2024 · GM

Selective C(sp3)-H Oxidations and Functionalizations with Tunable Metal Catalysts for Synthesis

$549,475
Maria Christina White · University Of Illinois At Urbana-Champaign · R35 · FY2025 · GM

Identifying phosphoribosylformylglycinamidine synthase inhibitors as a new class of purine antimetabolites

$549,474
Jarrod B French · University Of Minnesota · R01 · FY2025 · CA

Molecular Mechanisms of Cell-Cell Attachment

$549,429
Tina Izard · University Of Florida · · FY2022 · BIO

Mechanotransduction in Intestinal Smooth Muscle Cells

$549,415
Gianrico Farrugia · Mayo Clinic Rochester · R01 · FY2022 · DK

Network-based algorithms for target identification and drug repositioning from genetic associations

$549,393
Casey S Greene · University Of Colorado Denver · R01 · FY2022 · HG

Epigenetic mechanisms of inflammatory memory propagation in human airway epithelia

$549,375
Alejandro Antonio Pezzulo · University Of Iowa · R01 · FY2024 · HL

Training in Pharmacological Sciences

$549,359
David E. Golan · Harvard Medical School · T32 · FY2024 · GM

In vivo Imaging Analysis of SteroidNuclear Receptor Function

$549,339
Gordon L Hager · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Mechanisms controlling the efficiency of hemostatic vitamin K-dependent protein activation

$549,308
Kathleen Lucile Berkner · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · HL

Mechanisms controlling the efficiency of hemostatic vitamin K-dependent protein activation

$549,308
Kathleen Lucile Berkner · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · HL

Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma

$549,284
Yuan Chen · University Of California, San Diego · R01 · FY2020 · CA

Deterrents for prescription opioid abuse

$549,185
Kevin B. Freeman · University Of Mississippi Med Ctr · R01 · FY2022 · DA

High-activity mutants of cocaine esterase for treatment of drug addiction

$549,174
Chang-Guo Zhan · University Of Kentucky · R01 · FY2012 · DA

Enabling the Accelerated Discovery of Novel Chemical Probes by Integration of Crystallographic, Computational, and Synthetic Chemistry Approaches

$549,141
Alexander Tropsha · Univ Of North Carolina Chapel Hill · R01 · FY2022 · GM

Preclinical/Co-Clinical Section

$549,135
Cathleen M Lutz · Jackson Laboratory · U54 · FY2025 · OD

Systematic elucidation of calcineurin phosphatase signaling in humans

$549,130
Martha S Cyert · Stanford University · R35 · FY2023 · GM

Systematic elucidation of calcineurin phosphatase signaling in humans

$549,130
Martha S Cyert · Stanford University · R35 · FY2022 · GM

Systematic elucidation of calcineurin phosphatase signaling in humans

$549,130
Martha S Cyert · Stanford University · R35 · FY2024 · GM

Deciphering how tissue resident macrophages regulate musculoskeletal regeneration in spiny mice

$549,115
Ashley Winn Seifert · University Of Kentucky · R01 · FY2025 · AR

Microphysiologial systems and low cost microfluidic platform with analytics

$549,095
Michael L Shuler · Cornell University · UH2 · FY2014 · TR

R-Spondin3 as a target for anabolic bone therapy

$549,085
Roland E Baron · Harvard Medical School · R01 · FY2016 · AR

R-Spondin3 as a target for anabolic bone therapy

$549,085
Roland E Baron · Harvard Medical School · R01 · FY2014 · AR

R-Spondin3 as a target for anabolic bone therapy

$549,085
Roland E Baron · Harvard Medical School · R01 · FY2018 · AR